The Impact of the Combined Vaccination Scheme Against Streptococcus Pneumoniae on the Incidence of Related Infections in Patients with Rheumatoid Arthritis Treated with Biologic or Targeted Synthetic DMARD: Data from BIOBADASER 3.0
14/08/2023
Sebastian Rodriguez-Garcia1, Carlos Sanchez-Piedra2, Raul Castellanos-Moreira3, Dolores Ruiz-Montesinos4, Victoria Hernandez5, Manuel Pombo-Suarez6, Fernando Sanchez-Alonso2, Loreto Carmona7 and JJ Gómez-Reino8,
ACR 2020
Rodriguez-Garcia S, Sanchez-Piedra C, Castellanos-Moreira R, Ruiz-Montesinos D, Hernandez V, Pombo-Suarez M, Sanchez-Alonso F, Carmona L, Gómez-Reino J. The Impact of the Combined Vaccination Scheme Against Streptococcus Pneumoniae on the Incidence of Related Infections in Patients with Rheumatoid Arthritis Treated with Biologic or Targeted Synthetic DMARD: Data from BIOBADASER 3.0 [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/the-impact-of-the-combined-vaccination-scheme-against-streptococcus-pneumoniae-on-the-incidence-of-related-infections-in-patients-with-rheumatoid-arthritis-treated-with-biologic-or-targeted-synthetic/
https://acrabstracts.org/abstract/the-impact-of-the-combined-vaccination-scheme-against-streptococcus-pneumoniae-on-the-incidence-of-related-infections-in-patients-with-rheumatoid-arthritis-treated-with-biologic-or-targeted-synthetic/